Accessibility Menu
 
STAAR Surgical logo

STAAR Surgical

(NASDAQ) STAA

Current Price$20.27
Market Cap$1.00B
Since IPO (1984)-15%
5 Year-81%
1 Year+15%
1 Month+7%

STAAR Surgical Financials at a Glance

Market Cap

$1.00B

Revenue (TTM)

$239.44M

Net Income (TTM)

$80.45M

EPS (TTM)

$-1.63

P/E Ratio

-12.40

Dividend

$0.00

Beta (Volatility)

1.39 (Average)

Price

$20.27

Volume

27,683

Open

$19.31

Previous Close

$20.27

Daily Range

$19.28 - $20.32

52-Week Range

$14.69 - $30.81

STAA: Motley Fool Moneyball Superscore

55

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About STAAR Surgical

Industry

Healthcare Equipment and Supplies

Employees

957

CEO

Stephen C. Farrell, MBA, CPA

Headquarters

Lake Forest, CA 92630, US

STAA Financials

Key Financial Metrics (TTM)

Gross Margin

76%

Operating Margin

-33%

Net Income Margin

-34%

Return on Equity

-22%

Return on Capital

-20%

Return on Assets

-17%

Earnings Yield

-8.06%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.00B

Shares Outstanding

49.51M

Volume

27.68K

Short Interest

0.00%

Avg. Volume

1.51M

Financials (TTM)

Gross Profit

$176.90M

Operating Income

$45.87M

EBITDA

$37.18M

Operating Cash Flow

$34.23M

Capital Expenditure

$5.82M

Free Cash Flow

$40.05M

Cash & ST Invst.

$187.54M

Total Debt

$38.35M

STAAR Surgical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$57.80M

+18.1%

Gross Profit

$42.41M

+34.0%

Gross Margin

73.37%

N/A

Market Cap

$1.00B

N/A

Market Cap/Employee

$864.87K

N/A

Employees

1,157

N/A

Net Income

$18.31M

+46.5%

EBITDA

$8.77M

+65.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$149.18M

-22.2%

Accounts Receivable

$54.61M

-31.1%

Inventory

$55.50M

+28.2%

Long Term Debt

$32.48M

-6.7%

Short Term Debt

$5.87M

+49.2%

Return on Assets

-17.43%

N/A

Return on Invested Capital

-20.29%

N/A

Free Cash Flow

$5.59M

-10.0%

Operating Cash Flow

$3.91M

-709.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AZTAAzenta, Inc.
$22.63+6.85%
BLFSBioLife Solutions, Inc.
$19.51+1.14%
ORICORIC Pharmaceuticals, Inc.
$8.89+18.93%
KMTSKestra Medical Technologies, Ltd.
$19.84-1.05%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.31-0.02%

Questions About STAA

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.